Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants

Volume: 376, Issue: 13, Pages: 1245 - 1255
Published: Mar 29, 2017
Abstract
BackgroundStudies in animals and in humans have suggested that docosahexaenoic acid (DHA), an n−3 long-chain polyunsaturated fatty acid, might reduce the risk of bronchopulmonary dysplasia, but appropriately designed trials are lacking. MethodsWe randomly assigned 1273 infants born before 29 weeks of gestation (stratified according to sex, gestational age [<27 weeks or 27 to <29 weeks], and center) within 3 days after their first enteral feeding...
Paper Details
Title
Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants
Published Date
Mar 29, 2017
Volume
376
Issue
13
Pages
1245 - 1255
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.